Our study was to evaluate changes in transaminase levels (AST/ALT) over one week after methotrexate was given to rheumatoid arthritis patients. We evaluated 13 patients with RA taking stable doses of methotrexate, and then sequential blood samples were obtained over the course of 7 days.